Gastrointestinal Stromal Tumor Drug Market
1 Gastrointestinal Stromal Tumor (GIST) Drug Market Overview
1.1 Product Overview and Scope of Gastrointestinal Stromal Tumor (GIST) Drug
1.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type
1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Amcasertib
1.2.3 Anagrelide hydrochloride CR
1.2.4 APG-1351
1.2.5 Binimetinib
1.2.6 Others
1.3 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application
1.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Comparison by Application: (2022-2028)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Estimates and Forecasts
1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2017-2028
1.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2028
1.4.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Gastrointestinal Stromal Tumor (GIST) Drug Market Competition by Manufacturers
2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturers (2017-2022)
2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Sites, Area Served, Product Type
2.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation and Trends
2.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Gastrointestinal Stromal Tumor (GIST) Drug Players Market Share by Revenue
2.5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gastrointestinal Stromal Tumor (GIST) Drug Retrospective Market Scenario by Region
3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country
3.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
3.3.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country
3.4.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
3.4.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region
3.5.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country
3.6.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
3.6.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
3.7.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Analysis by Type
4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)
4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2022)
4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2017-2022)
5 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Analysis by Application
5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)
5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2017-2022)
5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Ariad Pharmaceuticals, Inc.
6.1.1 Ariad Pharmaceuticals, Inc. Corporation Information
6.1.2 Ariad Pharmaceuticals, Inc. Description and Business Overview
6.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.1.5 Ariad Pharmaceuticals, Inc. Recent Developments/Updates
6.2 Arog Pharmaceuticals, Inc.
6.2.1 Arog Pharmaceuticals, Inc. Corporation Information
6.2.2 Arog Pharmaceuticals, Inc. Description and Business Overview
6.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.2.5 Arog Pharmaceuticals, Inc. Recent Developments/Updates
6.3 Array BioPharma Inc.
6.3.1 Array BioPharma Inc. Corporation Information
6.3.2 Array BioPharma Inc. Description and Business Overview
6.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.3.5 Array BioPharma Inc. Recent Developments/Updates
6.4 Astex Pharmaceuticals, Inc.
6.4.1 Astex Pharmaceuticals, Inc. Corporation Information
6.4.2 Astex Pharmaceuticals, Inc. Description and Business Overview
6.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.4.5 Astex Pharmaceuticals, Inc. Recent Developments/Updates
6.5 Blueprint Medicines Corporation
6.5.1 Blueprint Medicines Corporation Corporation Information
6.5.2 Blueprint Medicines Corporation Description and Business Overview
6.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.5.5 Blueprint Medicines Corporation Recent Developments/Updates
6.6 Boston Biomedical, Inc.
6.6.1 Boston Biomedical, Inc. Corporation Information
6.6.2 Boston Biomedical, Inc. Description and Business Overview
6.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.6.5 Boston Biomedical, Inc. Recent Developments/Updates
6.7 Calithera Biosciences, Inc.
6.6.1 Calithera Biosciences, Inc. Corporation Information
6.6.2 Calithera Biosciences, Inc. Description and Business Overview
6.6.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.7.5 Calithera Biosciences, Inc. Recent Developments/Updates
6.8 Chipscreen Biosciences Ltd
6.8.1 Chipscreen Biosciences Ltd Corporation Information
6.8.2 Chipscreen Biosciences Ltd Description and Business Overview
6.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.8.5 Chipscreen Biosciences Ltd Recent Developments/Updates
6.9 Deciphera Pharmaceuticals, LLC
6.9.1 Deciphera Pharmaceuticals, LLC Corporation Information
6.9.2 Deciphera Pharmaceuticals, LLC Description and Business Overview
6.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.9.5 Deciphera Pharmaceuticals, LLC Recent Developments/Updates
6.10 F. Hoffmann-La Roche Ltd.
6.10.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.10.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.10.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.11 Horizon Pharma Plc
6.11.1 Horizon Pharma Plc Corporation Information
6.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview
6.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.11.5 Horizon Pharma Plc Recent Developments/Updates
6.12 Immunicum AB
6.12.1 Immunicum AB Corporation Information
6.12.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview
6.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.12.5 Immunicum AB Recent Developments/Updates
6.13 Jiangsu Hengrui Medicine Co., Ltd.
6.13.1 Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
6.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview
6.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates
6.14 Kolltan Pharmaceuticals, Inc.
6.14.1 Kolltan Pharmaceuticals, Inc. Corporation Information
6.14.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview
6.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.14.5 Kolltan Pharmaceuticals, Inc. Recent Developments/Updates
6.15 Natco Pharma Limited
6.15.1 Natco Pharma Limited Corporation Information
6.15.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview
6.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.15.5 Natco Pharma Limited Recent Developments/Updates
6.16 Nerviano Medical Sciences S.r.l.
6.16.1 Nerviano Medical Sciences S.r.l. Corporation Information
6.16.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview
6.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.16.5 Nerviano Medical Sciences S.r.l. Recent Developments/Updates
6.17 Novartis AG
6.17.1 Novartis AG Corporation Information
6.17.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview
6.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.17.5 Novartis AG Recent Developments/Updates
6.18 Omeros Corporation
6.18.1 Omeros Corporation Corporation Information
6.18.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview
6.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
6.18.5 Omeros Corporation Recent Developments/Updates
7 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Cost Analysis
7.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
7.4 Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
8.3 Gastrointestinal Stromal Tumor (GIST) Drug Customers
9 Gastrointestinal Stromal Tumor (GIST) Drug Market Dynamics
9.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Trends
9.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
9.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
9.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
10 Global Market Forecast
10.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2023-2028)
10.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gastrointestinal Stromal Tumor (GIST) Drug by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Gastrointestinal Stromal Tumor (GIST) Drug by Application (2023-2028)
10.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gastrointestinal Stromal Tumor (GIST) Drug by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Gastrointestinal Stromal Tumor (GIST) Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
Table 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
Table 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation by Manufacturers in 2021
Table 5. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Gastrointestinal Stromal Tumor (GIST) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumor (GIST) Drug as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2017-2022) & (K Pcs)
Table 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2017-2022)
Table 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2017-2022)
Table 19. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)
Table 20. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2017-2022)
Table 21. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2017-2022)
Table 23. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)
Table 24. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2017-2022)
Table 25. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2017-2022) & (K Pcs)
Table 28. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2017-2022)
Table 31. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)
Table 32. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2017-2022)
Table 33. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)
Table 36. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2017-2022)
Table 39. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
Table 40. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)
Table 41. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Type (2017-2022)
Table 43. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2017-2022) & (USD/Pcs)
Table 44. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Application (2017-2022)
Table 45. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)
Table 46. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Application (2017-2022)
Table 48. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2017-2022) & (USD/Pcs)
Table 49. Ariad Pharmaceuticals, Inc. Corporation Information
Table 50. Ariad Pharmaceuticals, Inc. Description and Business Overview
Table 51. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 52. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 53. Ariad Pharmaceuticals, Inc. Recent Developments/Updates
Table 54. Arog Pharmaceuticals, Inc. Corporation Information
Table 55. Arog Pharmaceuticals, Inc. Description and Business Overview
Table 56. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 57. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 58. Arog Pharmaceuticals, Inc. Recent Developments/Updates
Table 59. Array BioPharma Inc. Corporation Information
Table 60. Array BioPharma Inc. Description and Business Overview
Table 61. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 62. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 63. Array BioPharma Inc. Recent Developments/Updates
Table 64. Astex Pharmaceuticals, Inc. Corporation Information
Table 65. Astex Pharmaceuticals, Inc. Description and Business Overview
Table 66. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 67. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 68. Astex Pharmaceuticals, Inc. Recent Developments/Updates
Table 69. Blueprint Medicines Corporation Corporation Information
Table 70. Blueprint Medicines Corporation Description and Business Overview
Table 71. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 72. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 73. Blueprint Medicines Corporation Recent Developments/Updates
Table 74. Boston Biomedical, Inc. Corporation Information
Table 75. Boston Biomedical, Inc. Description and Business Overview
Table 76. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 77. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 78. Boston Biomedical, Inc. Recent Developments/Updates
Table 79. Calithera Biosciences, Inc. Corporation Information
Table 80. Calithera Biosciences, Inc. Description and Business Overview
Table 81. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 82. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 83. Calithera Biosciences, Inc. Recent Developments/Updates
Table 84. Chipscreen Biosciences Ltd Corporation Information
Table 85. Chipscreen Biosciences Ltd Description and Business Overview
Table 86. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 87. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 88. Chipscreen Biosciences Ltd Recent Developments/Updates
Table 89. Deciphera Pharmaceuticals, LLC Corporation Information
Table 90. Deciphera Pharmaceuticals, LLC Description and Business Overview
Table 91. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 92. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 93. Deciphera Pharmaceuticals, LLC Recent Developments/Updates
Table 94. F. Hoffmann-La Roche Ltd. Corporation Information
Table 95. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 96. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 97. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 98. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 99. Horizon Pharma Plc Corporation Information
Table 100. Horizon Pharma Plc Description and Business Overview
Table 101. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 102. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 103. Horizon Pharma Plc Recent Developments/Updates
Table 104. Immunicum AB Corporation Information
Table 105. Immunicum AB Description and Business Overview
Table 106. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 107. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 108. Immunicum AB Recent Developments/Updates
Table 109. Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
Table 110. Jiangsu Hengrui Medicine Co., Ltd. Description and Business Overview
Table 111. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 113. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates
Table 114. Kolltan Pharmaceuticals, Inc. Corporation Information
Table 115. Kolltan Pharmaceuticals, Inc. Description and Business Overview
Table 116. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 118. Kolltan Pharmaceuticals, Inc. Recent Developments/Updates
Table 119. Natco Pharma Limited Corporation Information
Table 120. Natco Pharma Limited Description and Business Overview
Table 121. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 122. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 123. Natco Pharma Limited Recent Developments/Updates
Table 124. Nerviano Medical Sciences S.r.l. Corporation Information
Table 125. Nerviano Medical Sciences S.r.l. Description and Business Overview
Table 126. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 127. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 128. Nerviano Medical Sciences S.r.l. Recent Developments/Updates
Table 129. Novartis AG Corporation Information
Table 130. Novartis AG Description and Business Overview
Table 131. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 132. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 133. Novartis AG Recent Developments/Updates
Table 134. Omeros Corporation Corporation Information
Table 135. Omeros Corporation Description and Business Overview
Table 136. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 137. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 138. Omeros Corporation Recent Developments/Updates
Table 139. Production Base and Market Concentration Rate of Raw Material
Table 140. Key Suppliers of Raw Materials
Table 141. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
Table 142. Gastrointestinal Stromal Tumor (GIST) Drug Customers List
Table 143. Gastrointestinal Stromal Tumor (GIST) Drug Market Trends
Table 144. Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
Table 145. Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
Table 146. Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
Table 147. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 148. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Type (2023-2028)
Table 149. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 150. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Type (2023-2028)
Table 151. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 152. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Application (2023-2028)
Table 153. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 154. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Application (2023-2028)
Table 155. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 156. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Region (2023-2028)
Table 157. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 158. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Region (2023-2028)
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type in 2021 & 2028
Figure 3. Amcasertib Product Picture
Figure 4. Anagrelide hydrochloride CR Product Picture
Figure 5. APG-1351 Product Picture
Figure 6. Binimetinib Product Picture
Figure 7. Others Product Picture
Figure 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application in 2021 & 2028
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2017-2028) & (US$ Million)
Figure 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (2017-2028) & (K Pcs)
Figure 15. Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Manufacturers in 2021
Figure 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Gastrointestinal Stromal Tumor (GIST) Drug Players: Market Share by Revenue in 2021
Figure 18. Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2017-2022)
Figure 20. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region in 2021
Figure 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2017-2022)
Figure 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region in 2021
Figure 23. U.S. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Taiwan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Philippines Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Vietnam Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. UAE Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Sales Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2017-2022)
Figure 48. Manufacturing Cost Structure of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 49. Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 50. Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Industry Market Size
